These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 856757)

  • 21. Pharmacochemical profile of iopromide.
    Muetzel W; Speck U
    AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Column gel chromatography of 125I-labelled metrizamide. An experimental investigation in rabbit, rat and cat.
    Golman K
    Acta Radiol Suppl; 1973; 335():292-9. PubMed ID: 4534568
    [No Abstract]   [Full Text] [Related]  

  • 23. Distribution and retention of 125I-labelled metrizamide after intravenous and suboccipital injection in rabbit, rat and cat.
    Golman K
    Acta Radiol Suppl; 1973; 335():300-11. PubMed ID: 4534569
    [No Abstract]   [Full Text] [Related]  

  • 24. Excretion of metrizamide. IV. An experimental investigation in rabbit with impaired renal function.
    Golman K
    Acta Radiol Suppl; 1973; 335():268-74. PubMed ID: 4534565
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of the distal nephron mechanisms in the concentration of contrast medium in the urine.
    Webb JA
    Br J Radiol; 1984 May; 57(677):381-6. PubMed ID: 6722432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of subarachnoid contrast medium into rabbit spinal cord. Comparison between metrizamide and iohexol.
    Holtas S; Morris TW; Ekholm SE; Isaac L; Fonte D
    Invest Radiol; 1986 Feb; 21(2):151-5. PubMed ID: 3514535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of water-soluble contrast media from the subarachnoid space. Investigation with computer tomography.
    Hindmarsh T
    Acta Radiol Suppl; 1975; 346():45-9. PubMed ID: 181951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of aqueous myelographic contrast media from the subarachnoid space.
    Eldevik OP; Haughton VM; Sasse EA
    Invest Radiol; 1980; 15(6 Suppl):S260-3. PubMed ID: 7203932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetration.
    Kerber CW; Sovak M; Ranganathan RS; Heilman CB
    AJNR Am J Neuroradiol; 1983; 4(3):317-8. PubMed ID: 6410732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of urographic contrast media.
    Kelly M; Golman K
    Invest Radiol; 1981; 16(2):159-64. PubMed ID: 7216706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacology of nonionic roentgen contrast media].
    Turnheim K
    Wien Klin Wochenschr; 1986 May; 98(11):333-8. PubMed ID: 3727593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iopamidol: new preclinical and clinical data.
    Bonati F; Felder E; Tirone P
    Invest Radiol; 1980; 15(6 Suppl):S310-6. PubMed ID: 7203941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metrizamide in experimental urography. I. Iodine concentration and flow of urine following intravenous injection of an ionic and non-ionic contrast medium in rabbits.
    Golman K; Almén T
    Acta Radiol Suppl; 1973; 335():312-22. PubMed ID: 4534570
    [No Abstract]   [Full Text] [Related]  

  • 34. Metrizamide in experimental urography. VI. Effects of renal contrast media on urinary solutes.
    Golman K; Almén T
    Acta Pharmacol Toxicol (Copenh); 1976 Feb; 38(2):120-36. PubMed ID: 946375
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein binding of metrizamide and the effect on various enzymes.
    Salvesen S; Frey K
    Acta Radiol Suppl; 1973; 335():247-52. PubMed ID: 4534560
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous urography with low-osmolality contrast agents: theoretical considerations and clinical findings.
    Dawson P; Heron C; Marshall J
    Clin Radiol; 1984 May; 35(3):173-5. PubMed ID: 6713791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal excretion mechanism of a nonionic contrast agent.
    Golman K; Wilk I
    Invest Radiol; 1979; 14(3):224-7. PubMed ID: 468494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxic effect of intracranial subarachnoid application of metrizamide and meglumine iocarmate. An experimental investigation in dogs in neurolept analgesia.
    Grepe A; Widén L
    Acta Radiol Suppl; 1973; 335():102-18. PubMed ID: 4534544
    [No Abstract]   [Full Text] [Related]  

  • 39. Metrizamide in experimental urography. III. Effects of temporary ureteric stasis on urinary iodine concentration after intravenous injection of ionic and non-ionic contrast media.
    Almén T; Härtel M; Golman K
    Acta Radiol Suppl; 1973; 335():330-8. PubMed ID: 4534572
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of contrast media on aortic endothelium. Experiments in the rat with non-ionic monomeric and monoacidic dimeric contrast media.
    Nyman U; Almén T
    Acta Radiol Suppl; 1980; 362():65-71. PubMed ID: 6168170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.